43 ms·

I'm pretty sure one of the reasons clinical trials are so expensive is regulatory capture. If the trials are expensive only the biggest of the biggest can affor

I'm pretty sure one of the reasons clinical trials are so expensive is regulatory capture. If the trials are expensive only the biggest of the biggest can afford them. I mean, the methods employed remain the same for years and years but the costs balloon. It doesn't have to be this way. So, I don't really swallow this "oh, but we have to have high prices because it's costly to research drugs!". If the cost of developing drugs is so high, then in my opinion we should be looking at a state-effort. But I highly doubt anyone in the pharmaceutical industry would be okay with the government setting up a program for research and development that produced open drugs. Ultimately, pharmaceuticals are not losing money. Like, at all. These are some of the most profitable businesses there are and due to the costs it's a market that's been completely captured by a few players. It's impossible for people to even think they could start a pharmaceutical company today. And I believe this is simply because they themselves benefit of this lack of access/high costs of research. I don't know, this topic makes me a bit angry and frustrated at the state of the world.

sowbug 2y ago
The high R&D costs justify the high profits, the high exec salaries, and the high prices. And every company can point at the others and say "see, this is what it costs to hire the best in this industry. Sorry!" It's almost as bad in Big Tech, which doesn't even have pharma's level of regulatory capture. Maybe this is all textbook supply and demand. But it sure feels broken.
refurb 2y ago
Ultimately, pharmaceuticals are not losing money. Like, at all. What do you mean? Plenty of start-ups go under after the drug they try to bring to market fails. Or are you just looking at the successful companies? If so, you're not look at the entire industry.

sowbug 2y ago

The high R&D costs justify the high profits, the high exec salaries, and the high prices. And every company can point at the others and say "see, this is what it costs to hire the best in this industry. Sorry!" It's almost as bad in Big Tech, which doesn't even have pharma's level of regulatory capture. Maybe this is all textbook supply and demand. But it sure feels broken.

refurb 2y ago

Ultimately, pharmaceuticals are not losing money. Like, at all. What do you mean? Plenty of start-ups go under after the drug they try to bring to market fails. Or are you just looking at the successful companies? If so, you're not look at the entire industry.